RE:RE:RE:RE:RE:RE:RE:RE:Additional thoughts on the ATMNo need to apologize as those are legitimate points you are making. The company needs to keep getting better at selling their vision to investors. But first they need to decide what that vision is. Increasingly, it is looking like they are a cancer stock with an opportunity to revolutionize the way cancer is treated. Maybe they should approach Taimed to see if they want to buy the rights to both Trogarzo and Egrifta from them so they can focus on cancer. Weirdly, the stock's valauation would almost certainly benefit from such a move as having approved drugs bringing in a boringly slow growing stream of revenues does nothing for the stocks valaution.
scarlet1967 wrote: I apologize in advance for being so critical. The issue still is clear communication, shareholders of a public company shouldn’t have additional thoughts about big decisions made by the board, $50M is substantial amount of money for a small biotech like THTX and needs clear clarification re what is the purpose of the raise and why now just few months after previous offering. I believe there has been an internal argument between Paul and the board restraining him to do what he wants to do but again once you go up high enough in any organization you end up with one person who has the most influence. Among others clear communication and capital market engagements were some of the issues which were discussed during their interactions with Wino and the plan was to address it. How can shareholders believe their intentions to implement that plan were real if they issue a PR on a Friday evening re a ATM program for a substantial amount of money without saying a single word about what is their plan to do with that money?
This board has been so comfortable doing what the heck they want and get away with it, no decent justifications for their decisions, for instance the purpose of the previous offering was among others illiquidity, diversification of shareholders and market crash well the market crash didn’t happen the illiquidity was just an excuse and what do the board think the new shareholders or the leftovers after many sold for a small profit would react to more dilutions so far with no clarifications. All speculations re what is going on behind closed doors will not helping the stock. This very unnecessary uncertainty re their plans will only push future investor further away. Their second biggest investor asking very legit questions yet no luck. All these speculations make a speculative investment more and more speculative to a point that no one would want to get involved. Sometimes to me the board members come across as bunch of people who have no ideas what they want to do next and that is not helpful at all for a public company who is trying to convince the market to invest in them. So please get the overdue plan of reengineering going now.